a) Sequence alignment between the different MSC probes showing the polybasic stretch in each construct (or the associated mutations) and their respective net positive charges. Cationic residues (K, R) are in red, acidic residues (E, D) in light blue, hydrophobic and aromatic residues in the amphipatic helixes Rit-tail and KRphy are in dark blue (F, W, L, V), the C-terminal farnesylation sequence CVIM (CxxM box) is in green, the C-terminal geranylgeranylation sequence CAIL (CxxL box) is in purple and, the N-terminal myristoylation sequence MGSSK is in pink.
b) Schematic representation of the lipid modifications used in our MSC probes: myristoyl (pink, N-terminal modification, covalently linked to the second glycine), farnesyl (green, C-terminal modification, covalently linked to the cysteine in the CxxM motif) and geranylgeranyl (purple, C-terminal modification, covalently linked to the cysteine in the CxxL motif).
c–f) Representative confocal images of root epidermal cells expressing the indicated MSC probe. All the constructs are expressed by the pUBQ10 promoter and are fused with cYFP at their N-terminus, except the myristoylated constructs, which are fused with cYFP at their C-terminus. bars, 5μm.
c) Localization of the full collection of farnesylated probes from 8Q-Farn (0+) to 8K-Farn (8+). The farnesylated MSC probes are based on the C-terminal tail of the human small GTPase K-Ras4B. K-Ras is targeted to the PM via a C-terminal farnesyl anchor in conjunction with an adjacent unstructured polybasic peptides made of 8 lysines. Our bioprobes consist of a fusion between a tandem repeat mCITRINE fluorescent protein (cYFP) and the K-Ras C-terminal tail, in which we modified the net positive charges via site directed mutagenesis of the lysine stretch. The least cationic probe (0+), in which 8 lysines have been substituted by glutamine (8Q-Farn), is localized in numerous endomembrane compartments. This suggests that farnesylation of the 8Q-probe is sufficient to provide membrane anchoring in the absence of its adjacent lysines and that this probe, which is targeted mainly by hydrophobic interactions, confers targeting to intracellular membranes. The gradual addition of cationic charges should increase electrostatic interactions with anionic lipids and thereby shift the probes localization toward more negatively charged membranes. Indeed, we observed that the more cationic the probe is, the more it is targeted to the PM at the expense of endomembrane localization.
d) The cysteine in the CxxM motif of 8K-Farn was substituted by an alanine thereby prohibiting C-terminal addition of a farnesyl lipid anchor (8K-noFarn). This non-farnesylated probe failed to associate with any membrane and was fully soluble, despite being strongly cationic (8+). This suggests that electrostatic interactions by themselves are not sufficient for membrane targeting and that stable membrane association requires some type of hydrophobic interactions.
e) Localization of the Myr-8Q (0+), Myr-4K4Q (4+) and Myr-8K (8+) probes. Note that, by contrast with the 8Q-Farn (Extended Data Fig. 1c, top left pannel) and 8Q-Gege probes (see main ), the Myr-8Q probe is already partly associated with the PM in the absence of electrostatic interactions. This showed that these different lipid anchors have different intrinsic targeting properties but that they each failed to provide PM specificity on their own. Nonetheless, like for the farnesylated reporters, the gradual addition of net positive charges next to the myristoyl modification gradually increases PM association: Myr-4K4Q (4+) has an intermediate PM/endomembrane localization and Myr-8K is specifically localized at the PM. Together, our results support the notion that strong electrostatic interactions provide PM specificity regardless of the lipid anchor type.
f) Localization of the KA1Kcc4p reporter at the PM and in the nucleus. Similar to KA1MARK1, KA1Kcc4p is specifically localized at the PM and not in endomembrane compartments, confirming that this specific localization at the cell surface is a property of the KA1 domain in general rather than a specific feature of the MARK1 protein. However, unlike KAMARK1, KA1Kcc4p was also partly localized in the cytosol and the nucleus, which makes this domain less convenient as a MSC readout. For this reason, from now on, we decided to use the KA1MARK1 domain in subsequent experiments.
g) Sensitivity of KA1MARK1 (left and middle panel) and 8K-Farn (8+ probe, right panel) to 90 min of BFA treatment at the indicated concentration. To show that BFA was active during our treatment we used the endocytic tracer FM4-64 and found that it was accumulated in BFA bodies at both 25 μM and 100 μM of BFA. FM4-64 was used at 1 μM and added 10 min prior confocal observations in the continuous presence of BFA.